ITDD - NIH Contract

Institute for Therapeutics Discovery & Development (ITDD) faculty will receive $8.3 million from the National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to investigate pharmaceutical alternatives to existing birth control methods. The primary goal of the five-year research contract is to both develop new non-hormonal male and female birth control drug targets and expand on existing targets.